contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Demant är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av hörapparater och hörslingor. Idag innehar bolaget verksamhet på global nivå där produkterna säljs under varierande varumärken. Produkterna nås via bolagets distributörer och försäljningskanaler. Utöver huvudverksamheten bedriver bolaget forskning inom diagnostik för mätning av hörselkvalitén. Bolaget grundades ursprungligen under 1904 och har sitt huvudkontor i Smörum.

Demant

4.12.2024 08:28:38 CET | Demant A/S | Financial CalendarCompany announcement no 2024-16 4 December 2024Financial calendar 2025 22 JanuaryDeadline for submission of items for the agenda of the...

4.12.2024 08:28:38 CET | Demant A/S | Financial CalendarCompany announcement no 2024-16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 December 2024Financial calendar 2025&nbsp;&nbsp;<table class="prs-table"><tbody><tr><td>22 January</td><td>Deadline for submission of items for the agenda of the annual general meeting*</td></tr><tr><td>15 January to 4 February&nbsp;</td><td>Quiet period prior to publication of Annual Report 2024</td></tr><tr><td>5 February&nbsp;</td><td>Annual Report 2024</td></tr><tr><td>6 March&nbsp;</td><td>Annual general meeting</td></tr><tr><td>16 April to 6 May&nbsp;</td><td>Quiet period prior to publication of Interim Management Statement</td></tr><tr><td>6 May&nbsp;</td><td>Interim Management Statement for Q1 2025</td></tr><tr><td>23 July to 12 August&nbsp;</td><td>Quiet period prior to publication of Interim Report 2025</td></tr><tr><td>12 August&nbsp;</td><td>Interim Report 2025</td></tr><tr><td>15 October to 4 November&nbsp;</td><td>Quiet period prior to publication of Interim Management Statement</td></tr><tr><td>4 November&nbsp;</td><td>Interim Management Statement for Q3 2025</td></tr></tbody></table>&nbsp;* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 6 March 2025, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2025.&nbsp;&nbsp;<table class="prs-table"><tbody><tr><td>Further information:Peter Pudselykke, Head of Investor RelationsPhone +45 2830 7638 <a href="http://www.demant.com">www.demant.com</a></td></tr></tbody></table>&nbsp;<h4>Contacts</h4><ul> <li> Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication &amp; Sustainability, +45 2264 9982, <a href="mailto:heey@demant.com">heey@demant.com</a> </li></ul><h4>About Demant A/S</h4>Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.<h4>Attachments</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13560112/14166790/14518/2024-16%20Financial%20calendar%202025.pdf">2024-16 Financial calendar 2025.pdf</a> </li></ul>

Demant A/S: Financiel calendar 2025

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon and Costco in Sweden: A looming threat that Nordic retailers ignore at their peril

22 January	Deadline for submission of items for the agenda of the annual general meeting^*
15 January to 4 February	Quiet period prior to publication of Annual Report 2024
5 February	Annual Report 2024
6 March	Annual general meeting
16 April to 6 May	Quiet period prior to publication of Interim Management Statement
6 May	Interim Management Statement for Q1 2025
23 July to 12 August	Quiet period prior to publication of Interim Report 2025
12 August	Interim Report 2025
15 October to 4 November	Quiet period prior to publication of Interim Management Statement
4 November	Interim Management Statement for Q3 2025

Contacts

About Demant A/S

Attachments

Beställ vårt nyhetsbrev — inget användarkonto krävs!